|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 | |
| A61K 38/19 | |||
| A61K 45/00 | |||
| A61K 39/00 |
| (11) | Number of the document | 1225870 |
| (13) | Kind of document | T |
| (96) | European patent application number | 00968692.4 |
| Date of filing the European patent application | 2000-10-05 | |
| (97) | Date of publication of the European application | 2002-07-31 |
| (45) | Date of publication and mention of the grant of the patent | 2006-12-27 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2000/027399 |
| Date | 2000-10-05 |
| (87) | Number | WO 2001/024771 |
| Date | 2001-04-12 |
| (30) | Number | Date | Country code |
| 412681 | 1999-10-05 | US |
| (72) |
Wood, Gary W., US
|
| (73) |
TVAX Biomedical, LLC,
500 West 112th Street, Kansas, MO 64114,
US
|
| (54) | COMPOSITION AND METHOD OF CANCER ANTIGEN IMMUNOTHERAPY |
| COMPOSITION AND METHOD OF CANCER ANTIGEN IMMUNOTHERAPY |